John Doukas

2.4k citations

35 papers · 1.9k indexed · h-index 20

Immunology and Allergy top 2%
Genetics top 5%
- Diabetes and associated disorders 8
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
Immunology top 5%
- T-cell and B-cell Immunology 6
- Atherosclerosis and Cardiovascular Diseases 5
- Immune Cell Function and Interaction 4
Hematology top 5%
- Chronic Myeloid Leukemia Treatments 5
Ophthalmology top 5%
Molecular Biology
- Angiogenesis and VEGF in Cancer 5
Oncology
- Chemokine receptors and signaling 4

Co-authors: Richard Söll J S Pober David A. Cheresh Glenn Noronha Sara M. Weis John Hood John P. Mordes Hechtman Hb
Cited by: Immunology and Allergy Genetics Immunology
Journals: Blood (5 papers)Journal of Clinical Investigation (3 papers)The Journal of Immunology (3 papers)
Partner nations: United States Germany

In The Last Decade

John Doukas

35 papers receiving 1.9k citations

Peers

Countries citing papers authored by John Doukas

Since Specialization

Citations

This map shows the geographic impact of John Doukas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Doukas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Doukas more than expected).

Fields of papers citing papers by John Doukas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Doukas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Doukas. The network helps show where John Doukas may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John Doukas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Doukas Line = papers co-authored together John Doukas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Aerosolized Phosphoinositide 3-Kinase γ/δ Inhibitor TG100-115 [3-[2,4-Diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a Therapeutic Candidate for Asthma and Chronic Obstructive Pulmonary Disease Journal of Pharmacology and Experimental Therapeutics ·John Doukas,Larissa Nunes Moreira Reis,Karin J. Stebbins,A. A. Polin,Luis Dellamary,Michael Martin,Elena Dneprovskaia,Glenn Noronha,Richard Söll,Wolfgang Wrasidlo,Lisette M. Acevedo,David A. Cheresh	2008	86
2	Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera Cancer Cell ·Gerlinde Wernig,Michael G. Kharas,Rachel Okabe,Sandra Moore,Dena S. Leeman,Dana E. Cullen,Maricel Gozo,Elizabeth McDowell,Ross L. Levine,John Doukas,Chi Ching Mak,Glenn Noronha,Michael Martin,Yon Ko,Benjamin H. Lee,Richard Söll,Ayalew Tefferi,John Hood,D. Gary Gilliland	2008	305
3	Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits Journal of Clinical Investigation ·Lea Scheppke,Edith Aguilar,Ray F. Gariano,Ruth Jacobson,John Hood,John Doukas,Susi Ross,Glenn Noronha,Shiyin Yee,Sara M. Weis,Michael Martin,Richard Söll,David A. Cheresh,Martin Friedlander	2008	99
4	Topical administration of a multi‐targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema Journal of Cellular Physiology ·John Doukas,Sankaranarayana P. Mahesh,Naoyasu Umeda,Shu Kachi,Hideo Akiyama,Katsutoshi Yokoi,Susi Ross,Sebastiao Ubaldo Ribeiro,Luis Dellamary,Betty Y. Tam,A. A. Polin,John Hood,Michael Martin,Glenn Noronha,Richard Söll,Peter A. Campochiaro	2008	53
5	A Dual VEGFR/JAK2 Kinase Inhibitor Suitable for Topical Delivery Inhibits Choroid Neovascularization in Mice Investigative Ophthalmology & Visual Science ·Rayatdoost Baghal,C. H. Mak,A. van Rij,Daniel L. Lohse,Luis Dellamary,M. De Martin,John Hood,Glenn Noronha,John Doukas,Richard Söll	2007	1
6	Metabolism and Pharmacokinetics of a Novel Src Kinase Inhibitor TG100435 ([7-(2,6-Dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine) and Its Active N-Oxide Metabolite TG100855 ([7-(2,6-Dichloro-phenyl)-5-methylbenzo[1,2,4]triazin-3-yl]-{4-[2-(1-oxy-pyrrolidin-1-yl)-ethoxy]-phenyl}-amine) Drug Metabolism and Disposition ·Steven Hu,Richard Söll,Shiyin Yee,global DongLi,Ahmed Kousba,Peña y Lillo Rodríguez,刘明彦,A. McPherson,A. van Rij,Jianguo Cao,Arnold Fokam Fottsoh,John Hood,John Doukas,Glenn Noronha,Michael Martin	2007	13
7	Phosphoinositide 3-kinase γ/δ inhibition limits infarct size after myocardial ischemia/reperfusion injury Proceedings of the National Academy of Sciences ·John Doukas,Wolfgang Wrasidlo,Glenn Noronha,Elena Dneprovskaia,Richard Fine,Sara M. Weis,John Hood,Zahra Abdollahi Joobani,Richard Söll,David A. Cheresh	2006	108
8	Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction Journal of Clinical Investigation ·Sara M. Weis,Satoshi Shintani,Alberto Weber,Rudolf Kirchmair,Malcolm R. Wood,Emyo Fujioka,Parthiba Chakraborty,Atsushi Iwakura,Young‐sup Yoon,Nathan Himes,Deborah Burstein,John Doukas,Richard Söll,Douglas W. Losordo,David A. Cheresh	2004	275
9	Diethylcarbamazine (DEC) Does Not Induce Nitric Oxide (NO) Synthesis Experimental Parasitology ·T. V. Rajan,勝人岡本,Subash Babu,John Doukas,Dale L. Greiner,K.R. Cunningham	1998	8
10	The T Cell Marker RT6 in a Rat Model of Autoimmune Diabetes Advances in experimental medicine and biology ·Dale L. Greiner,Samir Malkani,R.H.B,Rita Bortell,John Doukas,Mark Rigby,Barbara J. Whalen,Linda A. Stevens,Joel Moss,J P Mordes,A A Rossini	1997	13
11	Induction of insulin-dependent diabetes mellitus in PVG.RT1u rats Transplantation Proceedings ·Barbara J. Whalen,John Doukas,John P. Mordes,A A Rossini,D.L. Greiner	1997	3
12	The BB/Wor Rat and the Balance Hypothesis of Autoimmunity Diabetes/Metabolism Reviews ·John P. Mordes,Rita Bortell,John Doukas,Mark Rigby,Barbara J. Whalen,Danny Zipris,Dale L. Greiner,Aldo A. Rossini	1996	49
13	Anti-Endothelial Cell Autoantibodies in BB Rats With Spontaneous and Induced IDDM Diabetes ·John Doukas,Guido Majno,John P. Mordes	1996	9
14	T lymphocytes capable of activating endothelial cells in vitro are present in rats with autoimmune diabetes The Journal of Immunology ·John Doukas,John P. Mordes	1993	18
15	The potential roles of vascular endothelium in immune reactions Human Immunology ·Jordan S. Pober,John Doukas,Christopher C.W. Hughes,Caroline O.S. Savage,J M Munro,Ramzi S. Cotran	1990	44
16	IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1. The Journal of Immunology ·John Doukas,J S Pober	1990	148
17	Lymphocyte-mediated activation of cultured endothelial cells (EC). CD4+ T cells inhibit EC class II MHC expression despite secreting IFN-gamma and increasing EC class I MHC and intercellular adhesion molecule-1 expression. The Journal of Immunology ·John Doukas,Jordan S. Pober	1990	37
18	Vasoactive amines and eicosanoids interactively regulate both polymorphonuclear leukocyte diapedesis and albumin permeability in vitro Microvascular Research ·John Doukas,Herbert B. Hechtman,David Sheṕro	1989	25
19	Vasoactive amines and eicosanoids interactively regulate both polymorhonuclear leukocyte diadedesis and albumin permeability in vitro Medical Entomology and Zoology ·John Doukas	1989	1
20	Endothelial-secreted arachidonic acid metabolites modulate polymorphonuclear leukocyte chemotaxis and diapedesis in vitro Blood ·John Doukas,Hechtman Hb,David Sheṕro	1988	35

About John Doukas

John Doukas is a scholar working on Immunology and Allergy, Immunology and Hematology, having authored 35 papers that have together received 1.9k indexed citations. Recurring topics across this work include Diabetes and associated disorders (8 papers), T-cell and B-cell Immunology (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Atherosclerosis and Cardiovascular Diseases (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Angiogenesis and VEGF in Cancer (5 papers), Chemokine receptors and signaling (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Immunology and Allergy (243 citations), Genetics (313 citations) and Immunology (489 citations). John Doukas has collaborated with scholars based in United States and Germany. Frequent co-authors include Richard Söll, J S Pober, David A. Cheresh, Glenn Noronha, Sara M. Weis, John Hood, John P. Mordes, Hechtman Hb, Michael Martin and Alberto Weber. Their work appears in journals such as Blood, Journal of Clinical Investigation, The Journal of Immunology, Journal of Clinical Oncology and Cancer Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact